Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Leukemia |
Free Subscription
1 Ann Hematol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Leukemia is free of charge.
GLI1 polymorphisms influence remission rate and prognosis of young de novo acute
myeloid leukemia patients treated with cytarabine-based chemotherapy.
Ann Hematol. 2024 Apr 27. doi: 10.1007/s00277-024-05777.
PubMed
Abstract available
ONC212 enhances YM155 cytotoxicity by triggering SLC35F2 expression and
NOXA-dependent MCL1 degradation in acute myeloid leukemia cells.
Biochem Pharmacol. 2024;224:116242.
PubMed
Abstract available
T-bet suppresses proliferation of malignant B cells in chronic lymphocytic
leukemia.
Blood. 2024 Apr 29:blood.2023021990. doi: 10.1182/blood.2023021990.
PubMed
Abstract available
HA-1-targeted T cell receptor (TCR) T cell therapy for recurrent leukemia after
hematopoietic stem cell transplantation.
Blood. 2024 Apr 29:blood.2024024105. doi: 10.1182/blood.2024024105.
PubMed
Abstract available
Cannabinoids induce cell death in leukaemic cells through Parthanatos and
PARP-related metabolic disruptions.
Br J Cancer. 2024;130:1529-1541.
PubMed
Abstract available
Solar ultraviolet radiation exposure, and incidence of childhood acute
lymphocytic leukaemia and non-Hodgkin lymphoma in a US population-based dataset.
Br J Cancer. 2024 Feb 29. doi: 10.1038/s41416-024-02629.
PubMed
Abstract available
Cross-talk between leukemic and immune cells at the tumor microenvironment in
chronic lymphocytic leukemia: An update review.
Eur J Haematol. 2024 May 2. doi: 10.1111/ejh.14224.
PubMed
Abstract available
Fludarabine, cyclophosphamide, and rituximab as first-line treatment in patients
with chronic lymphocytic leukemia: A long-term analysis of the German CLL Study
Group (GCLLSG) registry.
Eur J Haematol. 2024 May 1. doi: 10.1111/ejh.14220.
PubMed
Abstract available
Evolution of natural killer cell-targeted therapy for acute myeloid leukemia.
Int J Hematol. 2024 May 1. doi: 10.1007/s12185-024-03778.
PubMed
Abstract available
Acute mixed-lineage leukemia treated with desensitization therapy prior to
HLA-haploidentical transplantation with high donor-specific antibodies.
Int J Hematol. 2024 Apr 27. doi: 10.1007/s12185-024-03775.
PubMed
Abstract available
CEBPA mutations in acute myeloid leukemia: implications in risk stratification
and treatment.
Int J Hematol. 2024 Apr 26. doi: 10.1007/s12185-024-03773.
PubMed
Abstract available
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or
Refractory FLT3-Mutated AML.
J Clin Oncol. 2024;42:1499-1508.
PubMed
Abstract available
Real-world patterns and sequences of targeted therapy use in chronic lymphocytic
leukemia and small lymphocytic lymphoma in the United States: a longitudinal
study.
Leuk Lymphoma. 2024 May 2:1-11. doi: 10.1080/10428194.2024.2331631.
PubMed
Abstract available
A systematic review of second-generation FLT3 inhibitors for treatment of
patients with relapsed/refractory acute myeloid leukemia.
Leuk Res. 2024;141:107505.
PubMed
Abstract available
Efficacy and safety of flumatinib in the treatment of newly diagnosed chronic
myeloid leukemia in the chronic phase: A real-world single-center retrospective
study, with a focus on premature drug discontinuation.
Leuk Res. 2024;142:107507.
PubMed
Abstract available
Racial and ethnic disparities in Acute Myeloid Leukemia: 15-year experience at a
safety net hospital system.
Leuk Res. 2024;141:107503.
PubMed
Abstract available
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.
Reply.
N Engl J Med. 2024;390:1634-1635.
PubMed
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.
N Engl J Med. 2024;390:1633-1634.
PubMed
Acute Promyelocytic Leukemia.
N Engl J Med. 2024;390:e42.
PubMed
Correction: Therapeutic targeting of necroptosis by Smac mimetic bypasses
apoptosis resistance in acute myeloid leukemia cells.
Oncogene. 2024 Apr 29. doi: 10.1038/s41388-024-03022.
PubMed
Control of acute myeloid leukemia and generation of immune memory in vivo using
AMV564, a bivalent bispecific CD33 x CD3 T cell engager.
PLoS One. 2024;19:e0300174.
PubMed
Abstract available
PML::RARA and GATA2 proteins interact via DNA templates to induce aberrant
self-renewal in mouse and human hematopoietic cells.
Proc Natl Acad Sci U S A. 2024;121:e2317690121.
PubMed
Abstract available
Thank you for your interest in scientific medicine.